Individual holder
REMYND N V
BE·3 granted patents·1 pending application·0 citations·filing 2018–2023
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
4 records- 0167US11939324B2Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disordersREMYND N V·Filed 2022·Granted Mar 26, 2024·0 cites·12 claims
- 0256US2025388592A1(aza)spiroheptane derivatives for the treatment of neurodegenerative disordersREMYND N V·Filed 2023·Application pending·0 cites
- 0350US11548881B2Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disordersREMYND N V·Filed 2018·Granted Jan 10, 2023·0 cites·12 claims
- 0438US12178805B2Inhibitors of PDE6Delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disordersREMYND N V·Filed 2018·Granted Dec 31, 2024·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when REMYND N V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →